within Pharmacolibrary.Drugs.ATC.V;

model V04CJ02
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00011666666666666667,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.016,
    k12             = 28,
    k21             = 28
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>V04CJ02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Protirelin, also known as thyrotropin-releasing hormone (TRH), is a synthetic tripeptide hormone used primarily as a diagnostic agent for evaluating the function of the anterior pituitary and the thyroid gland, particularly in the assessment of suspected hypothyroidism and disorders of the hypothalamus or pituitary gland. Its clinical use has largely declined and it is not widely approved for therapeutic purposes today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects following intravenous administration of protirelin.</p><h4>References</h4><ol><li><p>Sugimoto, T, et al., &amp; Morino, A (1996). Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats. <i>Arzneimittel-Forschung</i> 46(2) 114–127. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8720299/\">https://pubmed.ncbi.nlm.nih.gov/8720299</a></p></li><li><p>Bajoria, R, et al., &amp; Fisk, NM (1997). Pharmacokinetics and pharmacodynamics of TRH during pregnancy. <i>Obstetrics and gynecology</i> 90(2) 176–182. DOI:<a href=\"https://doi.org/10.1016/S0029-7844(97)00221-4\">10.1016/S0029-7844(97)00221-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9241288/\">https://pubmed.ncbi.nlm.nih.gov/9241288</a></p></li><li><p>Sugimoto, T, et al., &amp; Morino, A (1996). Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. <i>Arzneimittel-Forschung</i> 46(2) 106–113. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8720298/\">https://pubmed.ncbi.nlm.nih.gov/8720298</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end V04CJ02;
